HFA Premium Access

Progression of markers of cardiac structure and function in the Personalised prospective comparison of ARni with ArB in patients with natriuretic peptide eLEvation (PARABLE) clinical trial

Congress Session

About the speaker

Professor Mark Ledwidge

STOP-HF Unit, Dublin (Ireland)
0 follower

10 more presentations in this session

Sacubitril valsartan in real life: tolerance, clinical evolution and remodeled long term

Speaker: Doctor R. Bravo Marques (Marbella, ES)

Thumbnail

Security of neurohormonal blocking with sacubitril / valsartan, iSGLT2 and mineralocorticoid receptor antagonist in patients with heart failure with reduced eyection fraction and diabetes mellitus

Speaker: Doctor R. Bravo Marques (Marbella, ES)

Thumbnail

Improvement of NT-proBNP and NYHA values in patients with HFrEF and Sacubitril/Valsartan treatment

Speaker: Doctor C. Goena Vives (Mendaro, ES)

Thumbnail

Long-term prognostic impact of beta-blocker prescription during hospitalization for acute myocardial infarction

Speaker: Doctor F. Fonseca Goncalves (Vila Real, PT)

Thumbnail

Diabetic patients need higher loop diuretic doses: a report on acute and chronic heart failure patients

Speaker: Associate Professor P. Bettencourt (Porto, PT)

Thumbnail

Access the full session

Poster Session 1 - Pharmacology and Pharmacotherapy

Speakers: Professor M. Ledwidge, Doctor R. Bravo Marques, Doctor R. Bravo Marques, Doctor C. Goena Vives, Doctor F. Fonseca Goncalves...
Thumbnail

About the event

Image

Heart Failure 2019 - 6th World Congress on Acute Heart Failure

25 May - 28 May 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk